MUNDIPHARMA has added two new physical therapy devices to its pain management portfolio by acquiring the exclusive Australian and New Zealand rights to pain management device brands from Evomed.
The two physical therapy devices are: PAINmate - a "portable, wireless and affordable device that sends electrical nerve stimulation through the skin to provide fast and targeted pain relief", and ActiPatch -- a device that "dampens the brain's perception of pain by stimulating nerve activity with electromagnetic pulses".
The deal also includes exclusive Australian and New Zealand distribution rights for AccuVein, a device that digitally displays a map of blood vessels on the surface of the skin in real time - for more, visit mundipharma.com.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 04 Jul 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Jul 18
